Patricia L Allen's Net Worth

$3.04 Million

Estimate Recalculated Jul 12, 2024 07:04PM EST

Who is Patricia L Allen?

Patricia L Allen has an estimated net worth of $3.04 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Deciphera Pharmaceuticals, Inc., ZAFGEN, INC., and YUMANITY THERAPEUTICS, INC..

SEC CIK

Patricia L Allen's CIK is 0001348587

Past Insider Trading and Trends

2020 was Patricia L Allen's most active year for acquiring shares with 7 total transactions. Patricia L Allen's most active month to acquire stocks was the month of May. 2007 was Patricia L Allen's most active year for disposing of shares, totalling 52 transactions. Patricia L Allen's most active month to dispose stocks was the month of September. 2020 saw Patricia L Allen paying a total of $407,510.00 for 91,766 shares, this is the most they've acquired in one year. In 2020 Patricia L Allen cashed out on 49,000 shares for a total of $2,344,773.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $168.92

VP Finance and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 8
Form 4
—
0
—
—
0
Dec 10
Form 4
—
0
$9.29
-$416,995.00
0
Scheduled
Apr 22
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Dec 12
Form 4
-85.26%
-6.19K
$32.17
-$199,141.33
1.07K
Scheduled
Oct 25
Form 4
+578.50%
6.19K
$16.41
-$420,989.52
7.26K
Scheduled
Oct 25
Form 4
—
0
—
—
0
Dec 14
Form 3
—
0
—
—
0
No matching records found

Deciphera Pharmaceuticals, Inc. (DCPH) Snapshot price: $14.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jan 16
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
$41.68
-$382,688.40
0
Jun 3 - Jun 5
Form 4
—
0
$35.04
-$1,554,575.11
0
Scheduled
Jan 24
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Oct 2
Form 3
—
0
—
—
0
No matching records found

ZAFGEN, INC. (LRMR) Snapshot price: $5.9

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Jan 27
Form 4
+421.83%
16K
$3.12
$49,861.80
19.79K
Jul 25 - Jul 26
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Feb 27
Form 3
—
0
—
—
0
No matching records found

YUMANITY THERAPEUTICS, INC. (KA) Snapshot price: $2.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Dec 22
Form 3
—
0
—
—
0
No matching records found